Supplement/Disease Claim Continuum Suggested By CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA acceptance of disease-treatment health claims and subsequent revision of the term "nutritive value" to reflect a dietary supplement ingredient's ability to restore normal/proper function is urged by the Consumer Healthcare Products Association.
You may also be interested in...
Nutritive Value Claim Disclaimer Undermines Consumer Confidence - Perrigo
Requiring the DSHEA disclaimer on dietary supplements making nutritive valued-based structure/function claims would dissuade consumers from buying products that provide significant, well-recognized health benefits, Perrigo tells FDA.
SSA Standard Should Focus On Claim Truthfulness, CHPA Says
The "significant scientific agreement" standard for dietary supplement and conventional food health claims should focus on the truthfulness of proposed health claims rather than the "validity" of the nutrient/disease relationship, the Consumer Healthcare Products Association asserts in Feb. 22 comments.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC